At Paradise Medical in Wailuku, we are committed to being your one?stop shop for quality healthcare and natural aesthetics in Maui. Part of that commitment is offering state?of?the?art screening technologies. We are pleased to offer the Galleri® Multi?Cancer Early Detection (MCED) test by GRAIL to our patients and to the Maui community at large.
What is the Galleri® MCED Test?
The Galleri test is a cutting?edge blood assay designed to detect cancer signals from many types of cancers—not just one—through methylation-based DNA signal detection in circulating cell-free DNA. Rather than targeting a single organ or cancer, Galleri screens across 50+ cancer types with a single blood draw.
It also attempts to predict a cancer signal origin (i.e. which tissue or organ is likely affected), which helps guide follow-up diagnostics.
Why Early Cancer Detection Saves Lives
Catching cancer early is one of the most effective ways to improve outcomes. Here’s why:
- Higher cure and survival rates when disease is localized and before spread.
- Less aggressive and more targeted treatment is often possible.
- Reduced morbidity and side effects compared to late-stage therapy.
- Peace of mind and better long-term health planning.
Because many cancers are asymptomatic until later stages, a tool like Galleri offers the opportunity to “see ahead of symptoms.”
Which Cancers Can Galleri Detect?
The Galleri test is validated to detect signals from over 50 cancers, including many that currently lack standard screening:
Some examples include:
- Pancreatic cancer
- Ovarian cancer
- Liver cancer
- Esophageal cancer
- Head & neck cancers
- Lymphomas
- Bladder cancer
- Lung cancer
- Colorectal / digestive tract cancers
- Breast cancer
- Prostate cancer
- Gallbladder cancer
- And rarer cancers
It is especially valuable for those cancers without established screening protocols (for which routine screening is not available or effective). (Galleri® Test)
However, Galleri doesn’t detect all cancers and doesn’t replace organ-specific screening (such as mammograms or colonoscopy). (Galleri® Test)
Sensitivity & Specificity: How Accurate Is the Test?
Specificity (i.e. rate of false positives) is very high: the Galleri test reports a specificity of ~99.5%, meaning very few false positives. (Galleri® Test)
Sensitivity (i.e. how often it correctly detects cancer) varies by cancer type and by stage:
- For pancreatic cancer: ~83.7% sensitivity overall (with lower sensitivity in early stage I) (GRAIL)
- For esophageal cancer: sensitivity ~85% across stages (GRAIL)
- For head & neck: ~85.7% in studied cohorts (GRAIL)
- For gallbladder cancer: ~70.6% in published data (lower sensitivity in early stage) (GRAIL)
Keep in mind:
- Sensitivity is higher for more advanced disease, often lower in stage I cancers.
- A “Cancer Signal Detected” result still requires follow-up diagnostic testing (imaging, biopsy, etc.). (Galleri® Test)
- A “No Signal Detected” result does not guarantee absence of cancer — false negatives can occur. (Galleri® Test)
Thus, Galleri is additive to current screening—not a replacement. (Galleri® Test)
Real-Life Stories: Video Testimonial You Can Watch
To bring this to life, here’s a video testimonial you can reference and embed (if your site supports video):
GRAIL Video — Investigational Device Study (IDE) of GALLERI Test – YouTube (discoveriesinhealthpolicy.com)
Additionally, GRAIL’s site hosts patient testimonial videos (e.g. “Patient Testimonial: Kevin”, “Patient Testimonial: Kara”, etc.). (Galleri® Test)
One compelling story is Valerie’s case: she had no symptoms, but the Galleri test flagged a signal for gallbladder origin. Subsequent imaging and surgery revealed a tumor—and she underwent treatment early, making a full recovery possible. (GRAIL)
“I feel like this test was made for me … we found it so soon.” (GRAIL)
And Kevin’s story is another strong example. He had no symptoms, took the Galleri test, and it flagged an esophageal cancer. Because it was caught early, his treatment was less invasive. (GRAIL)
“By doing this test, I think I’m given more time.” (GRAIL)
You can embed these videos or link them in your blog page to enhance credibility and emotional engagement.
Who Should Consider Galleri?
Galleri is currently intended for:
- Adults age 50+ or those with elevated cancer risk (family history, genetic predisposition) (Galleri® Test)
- As a complement to—not replacement for—standard screening (mammograms, colonoscopy, Pap tests, etc.) (Galleri® Test)
- People without known cancer or ongoing active treatment (Galleri® Test)
Decisions should be guided by your provider, taking into account medical history, risk profile, and preferences.
Get the Galleri Test at Paradise Medical in Wailuku
We’re proud to offer the Galleri® MCED test at Paradise Medical. Anyone in Wailuku or greater Maui can schedule this test with us—whether you’re an existing patient or new to our clinic.
Here’s how it works:
- Consultation: Meet with one of our providers to discuss whether Galleri is appropriate for you based on your risk factors.
- Order & Draw: We order the test and take your blood sample.
- Laboratory Analysis: The sample goes to GRAIL’s lab for processing.
- Results & Follow-up: We review results and, if a signal is detected, arrange further diagnostics and support.
By offering Galleri locally, we reduce barriers for Maui residents to access advanced early detection technology.
Call to Action: Schedule Your Galleri Screening
Don’t wait for symptoms. Early detection changes everything.
? Call Paradise Medical, Wailuku today to schedule your Galleri test
? Visit our website to learn more or book online
? Appointments available for new and existing patients
We believe in health and beauty together. At Paradise Medical, you can get comprehensive preventive care, including advanced cancer screening, as well as natural aesthetic services, all under one roof.
This content was created in part with the assistance of ChatGPT, an AI language model developed by OpenAI.